Physician profile
Laura Smith
NPI 1679380505
$301.54
in general payments reported to CMS, 2019-2025
10 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $23.43 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $102.17 | 2025 | Zoryve |
| Sobi, INC | $32.52 | 2025 | |
| Axsome Therapeutics, INC. | $29.91 | 2025 | Sunosi |
| Abbvie INC. | $26.80 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $26.55 | 2025 | Breztri |
| W. L. Gore & Associates, INC. | $23.43 | 2024 | Gore Cardioform Septal Occluder |
| Organon LLC | $20.09 | 2025 | Nexplanon |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.49 | 2025 | Caplyta |
| Merck Sharp & Dohme LLC | $13.58 | 2025 | Verquvo |
| Corium, LLC | $11.00 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.